D
David Henry
Researcher at Bond University
Publications - 562
Citations - 55078
David Henry is an academic researcher from Bond University. The author has contributed to research in topics: Poison control & Population. The author has an hindex of 89, co-authored 547 publications receiving 45563 citations. Previous affiliations of David Henry include University of Melbourne & University of Toronto.
Papers
More filters
Journal ArticleDOI
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan A C Sterne,Miguel A. Hernán,Barnaby C Reeves,Jelena Savović,Jelena Savović,Nancy D. Berkman,Meera Viswanathan,David Henry,Douglas G. Altman,Mohammed T. Ansari,Isabelle Boutron,James R. Carpenter,An-Wen Chan,Rachel Churchill,Jonathan J Deeks,Asbjørn Hróbjartsson,Jamie J Kirkham,Peter Jüni,Yoon K. Loke,Theresa D Pigott,Craig R Ramsay,Deborah L. Regidor,Hannah R. Rothstein,Lakhbir Sandhu,Pasqualina Santaguida,Holger J. Schünemann,Beverly Shea,Ian Shrier,Peter Tugwell,Lucy Turner,Jeffrey C. Valentine,Hugh Waddington,Elizabeth Waters,George A. Wells,Penny Whiting,Julian P T Higgins +35 more
TL;DR: Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
Journal ArticleDOI
Grading quality of evidence and strength of recommendations.
David C. Atkins,Dana Best,Peter A. Briss,Martin P Eccles,Yngve Falck-Ytter,Signe Flottorp,Gordon H. Guyatt,Robin Harbour,Margaret C Haugh,David Henry,Suzanne Hill,Roman Jaeschke,Gillian Leng,Alessandro Liberati,Nicola Magrini,James Mason,Philippa Middleton,Jacek Mrukowicz,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Tessa Tan-Torres Edejer,H. Varonen,Gunn Elisabeth Vist,John W Williams,Stephanie Zaza +26 more
TL;DR: A system for grading the quality of evidence and the strength of recommendations that can be applied across a wide range of interventions and contexts is developed, and a summary of the approach from the perspective of a guideline user is presented.
Journal ArticleDOI
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley Shea,Beverley Shea,Barnaby C Reeves,George A. Wells,Micere Thuku,Candyce Hamel,Julian Moran,David Moher,David Moher,Peter Tugwell,Vivian Welch,Elizabeth Kristjansson,David Henry,David Henry +13 more
TL;DR: This paper reports on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Journal ArticleDOI
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.
Beverley Shea,Candyce Hamel,George A. Wells,Lex M. Bouter,Elizabeth Kristjansson,Jeremy M. Grimshaw,David Henry,Maarten Boers +7 more
TL;DR: AMSTAR has good agreement, reliability, construct validity, and feasibility, and these findings need confirmation by a broader range of assessors and a more diverse range of reviews.
Journal ArticleDOI
Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
TL;DR: It is suggested that celecoxib in commonly used doses may not increase the risk, contradicts claims of a protective effect of naproxen, and raises serious questions about the safety of diclofenac, an older drug.